SG Americas Securities
TMCI icon

SG Americas Securities’s Treace Medical Concepts TMCI Stock Holding History

SG Americas Securities’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,751
Closed -$46K – 3708
2025
Q4 		$46K Buy
+18,751
New +$81.4K ﹤0.01% 3374
2025
Q2 		– Sell
-16,759
Closed -$141K – 3587
2025
Q1 		$141K Sell
16,759
-11,645
-41% -$105K ﹤0.01% 2795
2024
Q4 		$211K Buy
28,404
+4,813
+20% +$32.2K ﹤0.01% 2107
2024
Q3 		$137K Buy
+23,591
New +$152K ﹤0.01% 2808
2023
Q1 		– Sell
-8,236
Closed -$189K – 3556
2022
Q4 		$189K Buy
8,236
+288
+4% +$6.63K ﹤0.01% 2237
2022
Q3 		$175K Buy
+7,948
New +$154K ﹤0.01% 2425
2021
Q4 		– Sell
-3,848
Closed -$104K – 3802
2021
Q3 		$104K Buy
+3,848
New +$106K ﹤0.01% 3652

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SG Americas Securities's TMCI Position: Q1 2026 in Review

SG Americas Securities sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 18,751 shares — an estimated $46K sold.

SG Americas Securities first reported a position in TMCI in Q3 2021 and held it in 7 quarters. The position peaked at $211K in Q4 2024. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • SG Americas Securities reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 18,751 Treace Medical Concepts shares in Q1 2026, an estimated $46K.
  • SG Americas Securities first reported a position in Treace Medical Concepts in Q3 2021 and held it in 7 quarters.
  • SG Americas Securities's Treace Medical Concepts position peaked at $211K in Q4 2024.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.